Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rajesh Swaminathan

Interventional Cardiology Durham, NC Medical Doctor

NPI 1386759066 CMS profile 153066

508 Fulton St, Durham, NC 27705

Open in the dashboard

General payments

$81,652

141 records reported · program years 2019–2025

Research payments

$2,257

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$59,994

3 holdings reported · through program year 2025

Research they led as principal investigator

$1,265,970 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Rajesh Swaminathan of Durham, NC is reported in the CMS Open Payments database as having received $81,652 across 141 general payments and $2,257 in research payments paid to them. Separately, studies naming them as principal investigator received $1,265,970 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $59,994 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,847 12
2024 General $18,905 16
2023 General $17,693 21
2022 General $17,285 41
2021 General $2,679 10
2020 General $1,452 6
2019 General $15,791 35
2019 Research $2,257 1
2025 Ownership $19,998 1
2024 Ownership $19,998 1
2023 Ownership $19,998 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rajesh Swaminathan
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Rajesh Swaminathan were reported at $7,847. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Rajesh Swaminathan Interventional Cardiology median Middle half National median
2019 $15,791 $1,097 $329–$3,048 $163
2020 $1,452 $473 $161–$1,480 $114
2021 $2,679 $677 $233–$1,827 $132
2022 $17,285 $978 $333–$2,724 $149
2023 $17,693 $1,136 $382–$2,986 $160
2024 $18,905 $1,181 $395–$3,326 $164
2025 $7,847 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $34,161 34 payments
  2. Bard Peripheral Vascular, Inc. $10,448 3 payments
  3. Siemens Medical Solutions USA, Inc. $6,336 10 payments
  4. Acist Medical Systems, Inc. $5,889 1 payment
  5. Boston Scientific Corporation $5,054 24 payments
  6. Recor Medical Inc $4,641 8 payments
  7. Medtronic Vascular, Inc. $4,027 11 payments
  8. Biotronik Inc. $3,560 4 payments
  9. Cardiovascular Systems Inc. $3,527 6 payments
  10. Corindus Inc. $2,947 7 payments
  11. Other $1,061 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $49,575 12 payments
  2. Travel and Lodging $17,649 38 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,750 3 payments
  4. Food and Beverage $4,508 85 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,150 2 payments
  6. Honoraria $2,019 1 payment
Products named General payments · program years 2019–2025
  1. (9520) IGT Devices Undivided $33,863 30 payments
  2. HD-IVUS $5,889 1 payment
  3. Paradise Ultrasound Renal Denervation System $4,353 6 payments
  4. Resolute $4,027 11 payments
  5. Coronary Orbital Atherectomy System $3,527 6 payments
  6. PK Papyrus $2,600 1 payment
  7. CorPath GRX $928 6 payments
  8. General - Therapies $738 4 payments
  9. Orsiro Mission $600 1 payment
  10. PARADISE RENAL DENERVATION SYSTEM $288 2 payments
  11. Other $2,461 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $2,257 1 payment

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$15,560

Medicare's payments for the services billed

Medicare patients

48

Average age 72

Services billed

128

12 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 69%
Arthritis 56%
Diabetes 54%
Chronic kidney disease 54%
Atrial fibrillation 42%
Depression 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record